Compare Baxter International Inc (BAX) vs Nu Holdings Ltd (NU) Price & Performance

Baxter International (BAX) trades at $22.57, down 0.22% on the day, with mixed technical signals showing a bullish moving average trend but neutral oscillators. The company reported Q1 2026 earnings beat with $0.36 EPS versus $0.31 expected, though net income margin remains negative at -9.7%. Recent news highlights upcoming Q2 earnings call and sustainability initiatives, while analyst consensus sits at $22.67 price target with 42% buy ratings.

BAX faces fundamental challenges with negative profitability metrics and volatile cash flow, but valuation appears reasonable with P/S of 1.02. The stock offers potential upside to analyst targets if operational improvements materialize, though investors must weigh high debt levels and inconsistent earnings performance against turnaround prospects in the medical technology sector.

NU Holdings trades at $13.67, down 0.65% on the day, with strong fundamental performance including 26.72% net income margin and 30.04% ROE. The company shows impressive revenue growth from $3.0B in 2022 to $10.63B in 2025, with technical indicators showing a bullish trend supported by moving averages. Recent approval for banking operations in Mexico with 15 million customers provides significant growth catalyst.

NU presents a compelling growth story with expanding profitability and Latin American market penetration. The stock trades below analyst consensus target of $14.98, offering potential upside, though currency headwinds and credit risks in emerging markets remain concerns. With 54.55% analyst buy ratings and strong cash flow generation, the long-term outlook appears positive despite recent earnings misses.